Scientists hunt for genetic clues behind eye inflammation
NCT ID NCT02357238
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to uncover genetic mutations or variations linked to uveitis, an inflammatory eye disease. Researchers will collect blood samples from 1,500 patients with uveitis (including infectious types) and analyze their DNA. The goal is to better understand what causes the disease, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward genetic factors that cause uveitis, potentially guiding future treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find clear genetic links, and results may take years to impact patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIOUS UVEITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test allow uveitis patients to safely take less medication?
- New DNA test could revolutionize diagnosis of eye infections
- New drug aims to tame eye inflammation in uveitis patients
- New hope for kids with eye inflammation: baricitinib trial shows promise
- New study aims to uncover uveitis patterns in kids
- New trial aims to stop CMV eye inflammation from returning